We are here to help. Your condition may be rare, but you are not alone.
It is our mission to discover, develop and deliver innovative therapies that improve patients' quality of life.
We are proud to work in the field of rare and serious diseases and to provide therapy in many areas of treatment.
We also aim to make sure that nothing holds you back from getting the therapies you need.
We support investigator-initiated studies (IIS) that advance medical and scientific knowledge of CSL Behring products and the diseases they are designed to treat.
CSL's Heimburger Award recognizes the clinical and/or preclinical research of emerging coagulation specialists who are driven to improve the care of patients with bleeding disorders.
We are committed to producing safe, effective and superior medicines.
CSL Behring provides a wide range of treatments for people with rare or life-threatening illnesses.
Popular search terms:
Learn More About Idiopathic Thrombocytopenic Purpura (ITP)
Learn More About Fibrinogen Deficiency
Learn More About Alpha 1 Antitrypsin Deficiency
Americas
Asia Pacific
Middle East
Europe
